
Shares of Sonoma Pharmaceuticals, a manufacturer of products for humans and animals, rose nearly 20% in after-hours trading on June 17. The company published its annual report for the fiscal year ending March 31, 2024, just before the close of trading. Details During regular trading on Nasdaq on Monday, June…